Morphosys Ag (MOR) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
MorphoSys AG has announced a merger squeeze-out with Novartis BidCo Germany AG offering a cash compensation of EUR 68.00 per share for the transfer of shares from minority shareholders. This action is pending approval at the MorphoSys AG Annual General Meeting and subsequent registrations in commercial registers. The court-appointed expert auditor has preliminarily affirmed the fairness of the compensation amount.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.